tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alec Stranahan, 17 are a BUY (48.57%), 11 are a HOLD (31.43%), 7 are a SELL (20%).
Analyst Alec Stranahan, currently employed at BAML, carries an average stock price target met ratio of 57.08% that have a potential upside of 30.29% achieved within 234 days.
Alec Stranahan’s has documented 66 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CADL, Candel Therapeutics at 03-Sep-2025.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 5/10/2024. The price target of $12 was fulfilled within 3 days with a profit of $3.12 (35.14%) receiving and performance score of 117.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$-2.7 (-47.37%)
$3
3 months 4 days ago
(01-Jul-2025)
4/5 (80%)
$2.56 (581.82%)
127
Buy
$4
$-1.7 (-29.82%)
$4
1 years 2 months 3 days ago
(02-Aug-2024)
6/7 (85.71%)
$2.4 (150.00%)
659
Hold
$16
2 years 11 months 1 days ago
(04-Nov-2022)
1/1 (100%)
$-43.04 (-72.90%)
273
Buy
$13
$7.16 (122.60%)
$13
2 years 11 months 2 days ago
(03-Nov-2022)
10/10 (100%)
$-17.12 (-56.84%)
507
Buy
$15
$9.16 (156.85%)
3 years 1 months 12 days ago
(23-Aug-2022)
2/2 (100%)
$-38.28 (-71.85%)
302
Which stock is Alec Stranahan is most bullish on?
Which stock is Alec Stranahan is most reserved on?
What Year was the first public recommendation made by Alec Stranahan?
